Morgan Stanley Maintains Underweight on Invivyd, Lowers Price Target to $2
Morgan Stanley analyst Matthew Harrison maintains Invivyd (NASDAQ:IVVD) with a Underweight and lowers the price target from $3 to $2.
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 293 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday’s Mid-Day Session
Gainers
NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
AT&T, IBM, Las Vegas Sands And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Benzinga’s Top Ratings Upgrades, Downgrades For September 14, 2022
Upgrades
For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low of $2.89. Moreover, at the end of the last trading period, the closing price was at $4.26.
Morgan Stanley Initiates Coverage On Invivyd with Underweight Rating, Announces Price Target of $3
Morgan Stanley analyst Matthew Harrison initiates coverage on Invivyd (NASDAQ:IVVD) with a Underweight rating and announces Price Target of $3.